[
  {
    "ts": "2026-02-19T00:39:50+00:00",
    "headline": "End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations",
    "summary": "Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, Jefferies lowered its price target on Apogee Therapeutics Inc. (NASDAQ:APGE) to $95 from $98 while keeping its Buy rating on the stock. The analyst also reduced its risk-adjusted peak sales forecast for Apogee’s ’279 […]",
    "url": "https://finance.yahoo.com/news/end-apogee-apge-drug-collaboration-003950489.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "38cfd1c0-8260-34cd-ad59-8beeaac03463",
      "content": {
        "id": "38cfd1c0-8260-34cd-ad59-8beeaac03463",
        "contentType": "STORY",
        "title": "End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations",
        "description": "",
        "summary": "Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 13 hot stocks to buy with the highest upside potential. On February 2, Jefferies lowered its price target on Apogee Therapeutics Inc. (NASDAQ:APGE) to $95 from $98 while keeping its Buy rating on the stock. The analyst also reduced its risk-adjusted peak sales forecast for Apogee’s ’279 […]",
        "pubDate": "2026-02-19T00:39:50Z",
        "displayTime": "2026-02-19T00:39:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/574412b19d02a46fe9f73f0f2cd4dce3",
          "originalWidth": 847,
          "originalHeight": 565,
          "caption": "End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z76OS_3ikbyleYCRhYGkhA--~B/aD01NjU7dz04NDc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/574412b19d02a46fe9f73f0f2cd4dce3.cf.webp",
              "width": 847,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eOZIec9HqIDcG_bqW0X.xw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/574412b19d02a46fe9f73f0f2cd4dce3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/end-apogee-apge-drug-collaboration-003950489.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/end-apogee-apge-drug-collaboration-003950489.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "APGE"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "KYKOF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T00:38:20+00:00",
    "headline": "Amgen Details Oncology R&D Push, IMDELLTRA Expansion and LUMAKRAS Updates at Citi Summit",
    "summary": "Amgen (NASDAQ:AMGN) executives outlined the company’s oncology research and development priorities and provided updates on several key programs during Citi’s Virtual Oncology Leadership Summit. Jean-Charles Soria, senior vice president of global development in oncology, said Amgen’s framework emphas",
    "url": "https://www.marketbeat.com/instant-alerts/amgen-details-oncology-rd-push-imdelltra-expansion-and-lumakras-updates-at-citi-summit-2026-02-18/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "3b3ee7fe-d3ec-3c0a-954e-f92a9324ab8a",
      "content": {
        "id": "3b3ee7fe-d3ec-3c0a-954e-f92a9324ab8a",
        "contentType": "STORY",
        "title": "Amgen Details Oncology R&D Push, IMDELLTRA Expansion and LUMAKRAS Updates at Citi Summit",
        "description": "",
        "summary": "Amgen (NASDAQ:AMGN) executives outlined the company’s oncology research and development priorities and provided updates on several key programs during Citi’s Virtual Oncology Leadership Summit. Jean-Charles Soria, senior vice president of global development in oncology, said Amgen’s framework emphas",
        "pubDate": "2026-02-19T00:38:20Z",
        "displayTime": "2026-02-19T00:38:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/4909f551de818c56e42d3c9ab5f5456b",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Amgen logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/du5DeAl0vfsu8qD9DGoJyw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/4909f551de818c56e42d3c9ab5f5456b.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GeOU9jSAhtvzM5tx5QWlcw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/4909f551de818c56e42d3c9ab5f5456b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/amgen-details-oncology-rd-push-imdelltra-expansion-and-lumakras-updates-at-citi-summit-2026-02-18/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-details-oncology-r-d-003820310.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T13:00:07+00:00",
    "headline": "Possible Bearish Signals With Amgen Insiders Disposing Stock",
    "summary": "In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...",
    "url": "https://finance.yahoo.com/news/possible-bearish-signals-amgen-insiders-130007972.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b7284edf-623c-3bb5-8722-08096deb5051",
      "content": {
        "id": "b7284edf-623c-3bb5-8722-08096deb5051",
        "contentType": "STORY",
        "title": "Possible Bearish Signals With Amgen Insiders Disposing Stock",
        "description": "",
        "summary": "In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...",
        "pubDate": "2026-02-19T13:00:07Z",
        "displayTime": "2026-02-19T13:00:07Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ACuIXYrNeojUXbAJFhnPIg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B7CQJIEa.2c0sQ0XIU66pg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8ab44b8ef28c7f69299492d5b9c5a46c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/possible-bearish-signals-amgen-insiders-130007972.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/possible-bearish-signals-amgen-insiders-130007972.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]